Cargando…
Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy
Background: In the era of precision medicine, cancer treatment is increasingly tailored according to tumor-specific genomic alterations. The analysis of tumor-derived circulating nucleic acids in cerebrospinal fluid (CSF) by next generation sequencing (NGS) may facilitate precision medicine in the f...
Autores principales: | von Baumgarten, Louisa, Kumbrink, Jörg, Jung, Andreas, Reischer, Anna, Flach, Madeleine, Liebmann, Sibylle, Metzeler, Klaus H., Holch, Julian W., Niyazi, Maximilian, Thon, Niklas, Straube, Andreas, von Bergwelt-Baildon, Michael, Heinemann, Volker, Kirchner, Thomas, Westphalen, Christoph Benedikt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929982/ https://www.ncbi.nlm.nih.gov/pubmed/31903155 http://dx.doi.org/10.7150/thno.36884 |
Ejemplares similares
-
Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board
por: Heinrich, Kathrin, et al.
Publicado: (2022) -
Case Report: Drug-Induced (Neuro) Sarcoidosis-Like Lesion Under IL4 Receptor Blockade With Dupilumab
por: Tsitos, Stergios, et al.
Publicado: (2022) -
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
por: Guenther, Michael, et al.
Publicado: (2020) -
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
por: Guenther, Michael, et al.
Publicado: (2021) -
CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
por: Masouris, Ilias, et al.
Publicado: (2021)